Congenital heart defects are the result of abnormal development of mesodermal cells, which form the muscular portion of the heart, or neural crest-derived cells, which populate the cardiac outflow tract and aortic arches. Defects in the two population of cells usually occur in a segmental fashion resulting in abnormalities of distinct regions of the heart with neighboring regions being relatively normal. The long term goal of this proposal is to understand the independent molecular pathways and mechanisms which would control segmental cardiac development. This type of understanding is the first step in identifying the genes which cause heart defects in distinct regions of the heart. Specifically, we focus on elucidating the pathogenesis of isolated cardiac outflow tract defects and those which occur as part of DiGeorge/CATCH-22 (cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, and hypocalcemia associated with chromosome 22 microdeletion) syndrome. In both scenarios, a high percentage of affected individuals harbor a microdeletion of one allele of chromosome 22q11.2 and are thought to have a defect in neural crest-derived cells which populate the branchial and aortic arches and cardiac outflow tract. In contrast, conditions such as hypoplasia of the right or left ventricles have been thought to be the result of flow abnormalities during cardiogenesis. Our recent targeted deletion of the basic helix- loop-helix transcription factor, dHAND, suggests that a subset of cardiac outflow tract defects and hypoplastic right ventricle may be the result of excessive programmed cell death from single gene defects. Although dHAND-null embryos have hypoplasia of the neural crest-derived branchial and aortic arches and right ventricle, dHAND does not map to human chromosome 22. However, by subtraction cloning between wild type and dHAND-null embryos, we have found that a ubiquitin fusion degradation protein (UFD1) is downstream of dHAND and maps to the DiGeorge critical region of ch.22. We have shown that UFD1 is normally expressed in the branchial arches, cardiac outflow tract and right ventricle but is down-regulated in dHAND-null embryos. The UFD family has been studied in yeast where they represent a novel proteolytic pathway for degradation of cellular proteins. Targeted deletion of UFD1 in yeast results in cell death in a dose-dependent fashion, suggesting that the down-regulation of UFD1 may mediate the apoptosis seen in dHAND mutants. Having placed UFD1 as a candidate gene for CATCH-22 syndrome from a molecular pathway and mechanistic approach, we propose three major aims for this proposal: 1) to determine, in mice, the role of UFD1 during embryogenesis and if UFD1 is one of the genes responsible for a DiGeorge/CATCH-22-like phenotype, 2) to determine if mutations and/or deletions of UFD1 in humans contribute to cardiac outflow tract defects or subsets of CATCH-22, 3) to define the role of UFD1 and dHAND in cell survival during embryonic development.
The aims utilize in vivo models of yeast, mice and humans to understand the development of cardiac mesoderm and neural crest in normal and abnormal embryogenesis. In this fashion, we intend to approach the molecular basis for certain congenital heart defects, particularly those affecting the cardiac outflow tract and aortic arch in isolation and in CATCH-22 syndrome.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL062591-01
Application #
2841118
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Wang, Lan-Hsiang
Project Start
1999-04-01
Project End
2003-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Tsuchihashi, Takatoshi; Maeda, Jun; Shin, Chong H et al. (2011) Hand2 function in second heart field progenitors is essential for cardiogenesis. Dev Biol 351:62-9
Yu, Sangho; Crawford, Dianna; Tsuchihashi, Takatoshi et al. (2011) The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn 240:384-93
Cordes, Kimberly R; Srivastava, Deepak (2009) MicroRNA regulation of cardiovascular development. Circ Res 104:724-32
Fish, Jason E; Srivastava, Deepak (2009) MicroRNAs: opening a new vein in angiogenesis research. Sci Signal 2:pe1
Kwon, Chulan; Qian, Li; Cheng, Paul et al. (2009) A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nat Cell Biol 11:951-7
Nigam, Vishal; Srivastava, Deepak (2009) Notch1 represses osteogenic pathways in aortic valve cells. J Mol Cell Cardiol 47:828-34
Saxena, Ankur; Fish, Jason E; White, Michael D et al. (2008) Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117:2224-31
Ivey, Kathryn N; Sutcliffe, David; Richardson, James et al. (2008) Transcriptional regulation during development of the ductus arteriosus. Circ Res 103:388-95
Yamagishi, H; Yamagishi, C; Nakagawa, O et al. (2001) The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol 239:190-203
Garg, V; Yamagishi, C; Hu, T et al. (2001) Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev Biol 235:62-73

Showing the most recent 10 out of 15 publications